N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment

Medicine and Dentistry

• Ganglioglioma 100%
• Hydroxamic Acid 100%
• Amine Oxidase (Flavin Containing) Isoenzyme A 100%
• Histone Deacetylase 100%
• Neoplasm 33%
• Monoamine Oxidase A Inhibitor 33%
• IC50 33%
• Survival Rate 16%
• Cancer 16%
• Cell Death 16%
• Cell Growth 16%
• Tubulin 16%
• Translational Research 16%
• Acetylation 16%
• Histone H3 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Hydroxamic Acid 100%
• Amine Oxidase (Flavin Containing) Isoenzyme A 100%
• Histone Deacetylase 100%
• Monoamine Oxidase A Inhibitor 33%
• Neoplasm 33%
• IC50 33%
• Survival Rate 16%
• Tubulin 16%
• Histone H3 16%

Biochemistry, Genetics and Molecular Biology

• Histone Deacetylase 100%
• Monoamine Oxidase A 100%
• IC50 25%
• Acetylation 12%
• Isoform 12%
• Survival Rate 12%
• Tubulin 12%
• Tumor Volume 12%
• Cell Death 12%
• Cell Growth 12%
• Histone H3 12%